VMAT treatments, and it is based on correlation functions between EPID signals and doses in patient. The software is easy to implement for Varian, Elekta and Siemens linacs, and it is connected with the Record and Verify system of the Center, supplying the results in a few seconds. The method supplies two tests (i) the ratio R=(Diso/Diso,TPS) between the reconstructed and computed isocentre dose, with pass criteria of ±5% and (ii) a 2D γ-analysis between EPID images with the following pass criteria: the percentage of the points Pγ<1 should be higher than 90% for 3DCRT and 95% for IMRT and VMAT; the γ-mean should be less than 0.5 and 0.3 for 3DCRT and IMRT-VMAT respectively.
Purpose or Objective: To date no satisfactory treatment options exist for locally advanced lung cancer. Based on promising phase II studies, dose escalation gave hope for better local control. However, the phase III RTOG 0617 [1] dose escalation trial showed that treatment related deaths can increase. Strict normal tissue constraints, as well as focus on the actual delivered dose, are essential when aiming for safe dose escalation. For standard doses, adaptive radiotherapy (ART) has mainly been concerned with ensuring target coverage, but with escalated doses anatomical changes during treatment can result in critical over dosage of organs at risk (OARs). Furthermore, it is important to monitor doses to known OARs such as the heart, and other structures as connective tissue and chest wall, where we don't know the risk for high dose RT. The present study investigates the impact of anatomical changes during RT on the escalated dose distribution used in the Danish NARLAL2 dose escalation trial.
Material and Methods:
Fifteen patients (pts) with a standard treatment plan and an experimental dose escalation plan were analysed. The standard plan delivered a homogeneous dose of 66 Gy/ 33 fractions (fx) while the experimental plan delivered a heterogeneous escalated dose distribution. The dose escalation was driven by the most FDG-PET active region of the tumour and lymph nodes, with mean doses up to 95 Gy/ 33 fx and 74Gy/ 33 fx, respectively. The dose distribution was limited by constraints to the OARs (Table 1) . All pts had a surveillance scan (sCT) at fx 10 and ten pts also at fx 20. The original treatment plans were recalculated on the sCTs to evaluate the impact of inter-fractional changes during the RT course. For most OARs, a maximum dose constraint was set, allowing higher doses for < 1cm3 of the OAR. The number of pts with OARs reaching the maximum dose for the escalation plan, was determined. For some pts, the volume receiving doses above the maximum constraint, increased on the sCT. Volume increments ΔV > 1cm3 were made up.
Results:
At least one OAR reached maximum dose constraint on planning CT (pCT) for all pts. Of these, 9 pts showed doses to OARs increasing above maximum dose on sCT, see Table. Heart doses (V50Gy) increased more than 1cm3 (up to 19 cm3) in eight pts and in one pt the oesophagus was over dosed on the sCT. For connective tissue and chest wall, the volume receiving > 74 Gy increased more than 1cm3 on the sCT in 7 and 5 pts, respectively. The anatomical changes leading to higher OAR doses were tumour shrinkage (5 pt), body contour changes (3 pt) and resolving atelectasis (1 pt).The mean dose to the PET-GTVT was 92±3Gy. In six pts, the mean dose decreased more than 1% (up to 10%) on the sCT.
Conclusion:
Anatomical changes during RT may result in increased doses to OAR. Introduction of dose escalation therefore requires frequent evaluation of treatment plans and ART should be used in order to avoid over dosage of OARs. Material and Methods: ART intervention rules were implemented for lung cancer patients treated with definitive chemo-radiotherapy, in concordance with smaller PTV margins and daily online soft-tissue matching. Intervention rules derived from geometrical criteria for normal tissue and tumour changes. Violation of these for three consecutive fractions triggered an evaluation. If the observed change was suspected to lead to an underdosage of tumour/lymph nodes or an overdosage of normal tissue, a CT rescan and a replan were made. The original plan was recalculated on the rescan to evaluate the consequence of replanning for patients receiving a plan adaptation in a cohort of 235 consecutive patients treated with ART. For the first 50 patients, in order to assess the efficacy of the intervention rules, two additional surveillance CT scans were acquired during the RT course and the treatment plans were recalculated on these scans. The change in lung dose due to the implementation of ART was found comparing the treatment plans of the first 50 ART-patients with 50 pre-ART-patients.
Results: Due to ART, the PTV decreased from 569 cm3 to 398 cm3, and consequentially the mean lung dose decreased from 14.1 Gy (SE 0.6) to 12.6 (SE 0.6) Gy. The criterion for the need of adaptation was a decrease in target coverage of CTV>1% or PTV>3%. The cohort of patients with two surveillance scans showed coverage above this in 94% of the cases not replanned. Sixty-one (26%) patients treated with ART had at least one replan. In total 77 adaptations were made. Fifty three adaptations corrected for a decrease in overall target coverage. Figure 1 shows the extent of decrease and designates the reason for replanning. In five patients with several separate targets under dosage of one of the targets were seen. One patient was replanned in order to avoid overdosage of spinal cord. Three patients were replanned due to changes in atelectasis making match evaluation impossible. In 15 patients, target shrinkage or less conformal dose distributions counterbalanced the geometric shifts that triggered adaptation.
The implementation of soft-tissue match and ART secured high treatment precision and allowed safe margin reduction in terms of persistent target coverage. The reduced margins reduced the mean dose to the lung. 
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The need for anatomical landmarks in adaptive rectal cancer boost radiotherapy J.J.E. Kleijnen 
Purpose or Objective:
In rectal cancer 15% of the patients show a pathological complete response (pCR) after neoadjuvant chemo-radiotherapy and these patients show better overall survival. To increase this pCR rate, in several studies a boost dose is given to the tumor. To safely deliver this boost, insight in the tumor position is needed. Currently, online imaging techniques provide no contrast of the tumor. However, since tumors are situated in the rectal wall, which is visible on online imaging like CBCT, the rectal wall position may be used as a surrogate for the tumor position. We therefore investigate the feasibility of tracking a part of the rectal wall close to the initial tumor as a motion surrogate for the tumor, to be used in online adaptive boost radiotherapy in rectal cancer.
Material and Methods:
We scanned 16 patients daily on a 1.5T MRI scanner during a one-week short course of radiotherapy (5 times 5Gy). Rectum and tumor were delineated on the T2 weighted scan of each day. All scans were registered on bony anatomy, mimicking daily patient set-up. For both tumor and rectum separately, displacements from the first day to every other day were determined, by calculating per voxel the shortest distance to each delineation. To find out how proximate to the tumor we have to define our rectum motion surrogate, we selected that part of the rectum that lies within 1, 3, 5, 7 and 10 mm of the initial tumor (ProximateRectum). For each point on these ProximateRectums, we determined the nearest point of the tumor as corresponding point. Between all the corresponding points of ProximateRectum and tumor, the displacements to every day were correlated to each other. We also determined how much of the variance in tumor motion was explained by each ProximateRectum. These analysis were done for the 1, 3, 5, 7 and 10 mm ProximateRectum separately.
Results: Different motion patterns were found for tumor and ProximateRectums, especially when movement of the tumor is in cranial caudal direction, since no anatomical landmarks are available (see figure 1) . We found correlations of ρ = 0.66, 0.64, 0.55, 0.53 and 0.45 (all p ≤ 0.001) for ProximateRectum of respectively 1, 3, 5, 7 and 10 mm. This
